These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22858177)

  • 1. Bioavailability and tolerability of combination treatment with revaprazan 200 mg + itopride 150 mg: a randomized crossover study in healthy male Korean volunteers.
    Choi HY; Noh YH; Jin SJ; Kim YH; Kim MJ; Sung H; Jang SB; Lee SJ; Bae KS; Lim HS
    Clin Ther; 2012 Sep; 34(9):1999-2010. PubMed ID: 22858177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
    Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
    Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioequivalence study of a fixed dose combination of rabeprazole and itopride in healthy Indian volunteers.
    Sahoo BK; Das A; Agarwal S; Bhaumik U; Bose A; Ghosh D; Roy B; Pal TK
    Arzneimittelforschung; 2009; 59(9):451-4. PubMed ID: 19856792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.
    Yoon S; Lee H; Kim TE; Lee S; Chee DH; Cho JY; Yu KS; Jang IJ
    Drug Des Devel Ther; 2014; 8():123-8. PubMed ID: 24470753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetic evaluation of extended release itopride HCl pellets with once daily tablet formulation in healthy human subjects: a two treatment, four period crossover study in fasted and fed condition.
    Nasiri MI; Yousuf RI; Shoaib MH; Siddiqui F; Qazi F; Ahmed K; Anwer S; Zaheer K
    Drug Dev Ind Pharm; 2019 Mar; 45(3):415-422. PubMed ID: 30457018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and bioequivalence study of itopride HCl in healthy volunteers.
    Cho KJ; Cho W; Cha KH; Park J; Kim MS; Kim JS; Hwang SJ
    Arzneimittelforschung; 2010; 60(3):137-40. PubMed ID: 20422945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
    Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, open-label, single-dose, crossover, relative bioavailability study in healthy adults, comparing the pharmacokinetics of rabeprazole granules administered using soft food or infant formula as dosing vehicle versus suspension.
    Thyssen A; Solanki B; Treem W
    Clin Ther; 2012 Jul; 34(7):1636-45. PubMed ID: 22748970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
    Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
    Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ketoconazole and rifampicin on the pharmacokinetics of gemigliptin, a dipeptidyl peptidase-IV inhibitor: a crossover drug-drug interaction study in healthy male Korean volunteers.
    Noh YH; Lim HS; Jin SJ; Kim MJ; Kim YH; Sung HR; Choi HY; Bae KS
    Clin Ther; 2012 May; 34(5):1182-94. PubMed ID: 22534255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose, randomized crossover comparisons of different-strength imatinib mesylate formulations in healthy Korean male subjects.
    Kim KA; Park SJ; Kim C; Park JY
    Clin Ther; 2013 Oct; 35(10):1595-602. PubMed ID: 24060561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pharmacokinetic drug interactions between gemigliptin (dipeptidylpeptidase-4 inhibitor) and glimepiride (sulfonylurea) in healthy volunteers.
    Choi HY; Kim YH; Kim MJ; Lee SH; Bang K; Han S; Lim HS; Bae KS
    Drugs R D; 2014 Sep; 14(3):165-76. PubMed ID: 24962635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
    Cho HY; Yoon H; Park GK; Lee YB
    Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover study.
    Jung JA; Kim TE; Kim JR; Kim MJ; Huh W; Park KM; Lee SY; Ko JW
    Clin Ther; 2013 Jul; 35(7):985-94. PubMed ID: 23870608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.